Please login to the form below
Discover Valid Insight: a global market access company
From years of experience in market access and the pharmaceutical industry, to our trusted client partnerships, we share our insights into what we believe has led to the team’s success and growth over the years.
Company Details
Valid Insight
+44 (0) 20 3750 9833
Address:
152-160 City Road
Kemp House
London
EC1V 2NX
United Kingdom
Latest content on this profile
- Webinar: How to price a pharmaceutical product during a global economic recession
- How can you ensure your product achieves optimal market access during a global economic recession?
Valid Insight
- Are biobetters a market access opportunity?
- Biobetters are biologics that have been improved compared to the marketed originator, for example in efficacy, safety, tolerability or dosing regimen.
Valid Insight
- Why are new medicinal products denied reimbursement in France?
- Many medicinal products looking to launch are rejected for reimbursement in France. A manufacturer must convince the Transparency Committee that their product is safe, effective and offers added value relative to alternative treatments for successful market access. In this blog, we summarise the reasons for negative reimbursement decisions in 2017 and discuss common pitfalls manufacturers should avoid.
Valid Insight
- Using TRAVELLESS™ to provide tailored pharmaceutical training
- In May 2020, Valid Insight were scheduled to travel to Grenoble to deliver the market access modules as part of the Advanced Master’s in Biotechnology & Pharmaceutical Management programme with Grenoble Ecole de Management, a French graduate business school. The course has participants from varied backgrounds, but all from roles within the pharmaceutical industry.
Valid Insight
- The vicious circle of pharmaceutical tendering
- Pharmaceutical tendering and contracting has long been common in healthcare for medical devices and diagnostics; the Gulf Cooperation Council and the Jamaica Commodity Trading Company have been using pharmaceutical tendering since the 1970s. In the 1990s, international institutions such as the World Health Organisation and the World Bank endorsed tendering as the preferred procurement process for drugs.
Valid Insight
- The benefits of a expert-led market access strategy
- In order to support effective decision making and deliver sustained returns in a complex, dynamic healthcare environment, pharmaceutical, biotech and medical device companies need an expert-led market access strategy that considers the changing nature of the real-life marketplace. These strategies should not only focus on achieving the commercial objectives for a product but also enable it to outperform competitors throughout the product life cycle.
Valid Insight
